Henryk A. Domanski

Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene

Fredrik Mertens, Christopher D.�M. Fletcher, Cristina R. Antonescu et al. · Laboratory Investigation · 2005 · 316 citations · Full text

Medicine, Molecular Genetics, Pathology +17

Comprehensive genetic analysis identifies a pathognomonic <i>NAB2/STAT6</i> fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

Arezoo Mohajeri, Johnbosco Tayebwa, Anna Collin et al. · Genes Chromosomes and Cancer · 2013 · 277 citations

Life Sciences, Genetics, Oncology +17

The chimeric <i>FUS/CREB3l2</i> gene is specific for low‐grade fibromyxoid sarcoma

Ioannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D.�M. Fletcher et al. · Genes Chromosomes and Cancer · 2004 · 215 citations

Medicine, Genetics, Oncology +17

A novel <i><scp>SERPINE1–FOSB</scp></i> fusion gene results in transcriptional up‐regulation of <i><scp>FOSB</scp></i> in pseudomyogenic haemangioendothelioma

Charles Walther, Johnbosco Tayebwa, Henrik Lilljebjörn et al. · The Journal of Pathology · 2013 · 204 citations

Life Sciences, Molecular Biology, Oncology +15

Two genetic pathways, t(1;10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions

Karolin H. Nord, Raf Sciot, Johan Staaf et al. · The Journal of Pathology · 2009 · 152 citations

Veterinary Medicine, Genetics, Molecular Genetics +16